NF2 | Action Medical Research


Neurofibromatosis type 2: finding new treatments for young people with this rare and disabling disease

Research date: 1 September 2016 - 31 August 2018
Grant amount: £65,061.00

Around one in 35,000 people has a rare genetic illness called neurofibromatosis type two (NF2), which tends to be diagnosed during childhood and early adulthood.1 People with NF2 develop multiple benign tumours in the nervous system. Although they’re not cancerous, these tumours can cause distressing symptoms including hearing loss, speech...

Help us spread the word